Division of Plastic Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Aesthet Surg J. 2014 Jan 1;34(1):66-73. doi: 10.1177/1090820X13515676. Epub 2013 Dec 13.
Reduction mammaplasty is an established and effective technique to treat symptomatic macromastia. Variable rates of complications have been reported, and there is a continued need for better outcome assessment studies.
The authors investigate predictors of postoperative complications following reduction mammaplasty using the National Surgery Quality Improvement Program (NSQIP) data sets.
The 2005-2010 American College of Surgeons NSQIP databases were reviewed to identify primary encounters for reduction mammaplasty using Current Procedural Terminology code 19318. Two complication types were recorded: major complications (deep infection and return to operating room) and any complication (all surgical complications). Preoperative patient factors and comorbidities, as well as intraoperative variables, were assessed. A multivariate regression analysis was used to identify independent predictors of complications.
A total of 3538 patients were identified with an average age of 43 years and body mass index of 31.6 kg/m(2). Most patients underwent outpatient surgery (80.5%) with an average operative time of 180 minutes. The incidence of overall surgical complications was 5.1%. The following factors were independently associated with any surgical complications: morbid obesity (odds ratio [OR], 2.1; P < .001), active smoking (OR, 1.7; P < .001), history of dyspnea (OR, 2.0; P < .001), and resident participation (OR, 1.8; P = .01). The incidence of major surgical complications was 2.1%. Factors associated with major complications included active smoking (OR, 2.7; P < .001), dyspnea (OR, 2.6; P < .001), resident participation (OR, 2.1; P < .001), and inpatient surgery (OR, 1.8; P = .01).
This study demonstrates overall incidence of complications in 1 in 20 patients and a 1 in 50 incidence of a major surgical complication. Noteworthy findings include the identification of morbid obesity as a significant predictor of overall morbidity and active smoking as a strong predictor of major surgical morbidity. These data can assist surgeons in preoperative counseling and enhance perioperative decision making.
缩乳术是治疗有症状的巨乳症的一种成熟且有效的技术。据报道,其并发症发生率存在差异,因此需要进一步开展研究以更好地评估其治疗效果。
作者使用国家外科质量改进计划(NSQIP)数据库,分析缩乳术后并发症的预测因素。
本研究回顾了 2005-2010 年美国外科医师学会 NSQIP 数据库,采用手术操作分类代码 19318 识别缩乳术的初次就诊病例。记录了两种类型的并发症:主要并发症(深部感染和重返手术室)和任何并发症(所有手术并发症)。评估了术前患者因素和合并症以及术中变量。采用多变量回归分析确定并发症的独立预测因素。
共纳入 3538 例患者,平均年龄为 43 岁,体重指数为 31.6 kg/m2。大多数患者接受了门诊手术(80.5%),平均手术时间为 180 分钟。总的手术并发症发生率为 5.1%。以下因素与任何手术并发症独立相关:病态肥胖(比值比[OR],2.1;P<0.001)、吸烟(OR,1.7;P<0.001)、呼吸困难史(OR,2.0;P<0.001)和住院医师参与手术(OR,1.8;P=0.01)。主要手术并发症的发生率为 2.1%。与主要并发症相关的因素包括吸烟(OR,2.7;P<0.001)、呼吸困难(OR,2.6;P<0.001)、住院医师参与手术(OR,2.1;P<0.001)和住院手术(OR,1.8;P=0.01)。
本研究显示,20 例患者中约有 1 例出现并发症,50 例患者中约有 1 例出现严重手术并发症。值得注意的是,病态肥胖是整体发病率的一个重要预测因素,吸烟是严重手术发病率的一个重要预测因素。这些数据可以帮助外科医生进行术前咨询,并增强围手术期决策。